Ekso Liabilities And Stockholders Equity from 2010 to 2024

EKSO Stock  USD 1.12  0.06  5.66%   
Ekso Bionics Liabilities And Stockholders Equity yearly trend continues to be very stable with very little volatility. Liabilities And Stockholders Equity is likely to drop to about 26 M. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Ekso Bionics' total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2012-06-30
Previous Quarter
28.9 M
Current Value
29 M
Quarterly Volatility
14.6 M
 
Yuan Drop
 
Covid
Check Ekso Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ekso Bionics' main balance sheet or income statement drivers, such as Interest Expense of 271.3 K, Selling General Administrative of 8.7 M or Other Operating Expenses of 28.5 M, as well as many indicators such as Price To Sales Ratio of 1.8, Dividend Yield of 0.11 or PTB Ratio of 2.61. Ekso financial statements analysis is a perfect complement when working with Ekso Bionics Valuation or Volatility modules.
  
Check out the analysis of Ekso Bionics Correlation against competitors.

Latest Ekso Bionics' Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Ekso Bionics Holdings over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Ekso Bionics' Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ekso Bionics' overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Ekso Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean22,221,136
Geometric Mean3,898,854
Coefficient Of Variation72.26
Mean Deviation12,707,428
Median24,425,000
Standard Deviation16,056,057
Sample Variance257.8T
Range49.2M
R-Value0.69
Mean Square Error146.7T
R-Squared0.47
Significance0
Slope2,465,597
Total Sum of Squares3609.2T

Ekso Liabilities And Stockholders Equity History

202426 M
202328.9 M
202240.9 M
202149.2 M
202020.6 M
201921.9 M
201817.7 M

About Ekso Bionics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ekso Bionics income statement, its balance sheet, and the statement of cash flows. Ekso Bionics investors use historical funamental indicators, such as Ekso Bionics's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Ekso Bionics investors may use each financial statement separately, they are all related. The changes in Ekso Bionics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ekso Bionics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ekso Bionics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ekso Bionics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity28.9 M26 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Ekso Stock

When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out the analysis of Ekso Bionics Correlation against competitors.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.97)
Revenue Per Share
1.202
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.26)
Return On Equity
(0.81)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.